RUNX1 and neoplasm: We could speculate that in TNBC highly positive for RUNX1, that RUNX1 would drive a transcriptional programme in breast cancer cells resulting in production and secretion of high levels of cytokines which would then lead to recruitment of lymphocytic cells at the tumour site.